Pharma
Kauvery Hospital invests in Lifesigns
Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.
The bill would allow AI to be classified as a "practitioner licensed by law" to administer FDA-approved drugs.
Everly Health Solutions alleged that Walgreens broke the terms of a 2020 business contract during the COVID-19 pandemic.
The aim of the collaboration is to deliver better cost leadership, productivity enhancement and elicit greater value from the existing relationship.
The expansion includes prescribing capabilities and entry into the direct-to-consumer market.
The service gives pet owners the ability to have pet medications delivered to their homes.
The AI is based on modular RAG that goes beyond the structural limits of current large language models.
The company will use the funds to drive adoption of its platform and provide capital infusion for expansion in the health markets.
The aim is to provide long-term behavioral change focusing on weight loss and maintenance.
The money will be used to develop new medications and biologicals.